Abstract Dendritic cells (DCs) are antigen-presenting cells that can acquire tumour antigens and initiate cytotoxic Tcell reactions. Obesity has been proposed as a cause for tumours escaping immune surveillance, but few studies investigate the impact of other body composition parameters. We examined the relationship of DC phenotype with computer tomography ( There were no relationships between the fat indexes and the DC phenotype. These results highlight a direct relationship between muscle depletion and changes in stimulatory, migratory and fatty acid-processing potential of DC in patients with CRC.
Introduction
Dendritic cells (DCs) are the most potent antigen-presenting cells, capable of sampling antigens and initiating cytotoxic T lymphocyte response against cancer cells. Colorectal tumour antigens induce DC recruitment, maturation and cytokine release in order to generate effective T cell immune response [1] . Despite their crucial role in generating an immune response, DCs are a heterogeneous and rare type of immune cell. In cancer, tumour-derived factors appear to exploit this heterogeneity by producing a variety of immunosuppressive factors capable of affecting DC. Herber et al. gave an explanation as to how the host immune system can be compromised during cancer; an increase in lipid content of DCs diminishes their capacity to present antigens from tumour cells and to activate effector T cells [2] . O'Shea et al. study on the susceptibility to viral infection in severe obesity showed that obesity negatively impacts the ability of systemic DCs to mature and elicit appropriate T cell responses to a general stimulus [3] .
Upon recognition of a danger signal through their pathogen-associated molecular pattern receptors, DCs go through a maturation phase and then they migrate to the local lymph nodes where they present antigens to T cells and initiate an antigen-specific response by the adaptive immune system [4] . Mature DCs increase their capacity to process antigens and express the cytokines and co-stimulatory molecules such as CD40, CD80, CD83 and CD86 essential for an effective immune response. CCR7 expression on DCs promotes migration in response to relevant ligands to the local lymphoid tissues [5] . The role of scavenger receptors has recently been recognized in DC function, and it has been suggested that immune responses in cancer can be improved by manipulating the lipid levels in DCs [2] . The myeloid dendritic cells (mDC) and plasmacytoid dendritic cells (pDC) populations function as APCs following a similar maturation process, and they act synergistically to induce more effective immune responses [6] . But DCs are not exclusively immunogenic; recent studies suggested that depending on the local microenvironment and the type of disease DCs can initiate either an immunogenic or a tolerogenic response [7] . Colorectal cancer (CRC) cells use different mechanisms to escape the immune surveillance and cause immune dysfunction but also factors of the host such as body composition (BC) can play an important role [8] .
The interactions between tumour cells and DCs are complex and have yet to be fully comprehended. Certain characteristics of cancer such as stage may have an impact on the DC function and phenotype but again the evidence is limited. Associations between the disease stage, the grade, the location, the presence of lymphovascular invasion and, more importantly, features of the tumour host-the patient-such as the body composition (BC) and DC profiles have rarely been explored. BC describes the percentages of fat, bone and muscle in human bodies. BC changes have been documented in patients with malignant disease; however, associated metabolic and immune changes developing during disease and its legacy are less clear, particularly in CRC [9] .
Understanding the links between DCs, colorectal cancer tumours and BC profiles will lead to better understating of the immune surveillance and escape mechanisms and ultimately will provide novel therapeutic targets. Here, using circulating blood DCs and flow cytometric analysis, we identified relationships between BC anthropometric parameters, tumour characteristics and DC phenotype in patients with CRC.
Materials and methods

Study population
Consecutive patients undergoing colorectal cancer surgery at St Mark's Hospital, London between December 2012 and December 2013 were identified from a prospective database and considered for inclusion. Patients with recurrent or metastatic disease confirmed preoperatively or at surgery, emergency cases, those receiving neo-adjuvant treatment, patients with diabetes, history of smoking and blood transfusion, patients not willing to enroll in this study, and patients with American Society of Anesthesiologists (ASA) status >3 were excluded.
BC analysis
Preoperative CT scan images were retrieved from digital storage in the picture archiving and communication system [PACS] . CT image analysis Slice-O-Matic V4.3 software (Tomovision, Montreal, Canada) was performed as described previously [10] . Briefly, total skeletal muscle, subcutaneous and visceral fat surface areas (cm 2 ) were evaluated on a single image at the third lumbar vertebrae (L3) using Hounsfield unit (HU) thresholds. The sum of skeletal cross-sectional tissue areas was normalized for stature (m 2 ) and reported as lumbar skeletal muscle index (LSMI) (cm 2 m −2 ) and total adipose tissue index (cm 2 m −2 ). Reduced L3 skeletal muscle index (myopenia) and low muscle attenuation (MA) (myosteatosis) were defined using predefined sex-specific skeletal muscle index cut points. Increased visceral adipose tissue area (visceral obesity) was also described by using gender-specific and pathologically relevant cut-off values [11] [12] [13] . Myopenic obesity was defined as the combination of myopenia with a BMI of >30 kg/m 2 . Figure 1b shows how the different BC parameters were calculated through the CT images.
Blood samples and processing
Venous blood (20 ml) was collected from the selected CRC patients into heparinized Vacutainers (Becton Dickinson, Oxford, UK). Ficoll gradient-separated peripheral blood mononuclear cells (PBMC) were assessed for viability by their ability to exclude trypan blue (Sigma, Poole).
Antibody labeling
PBMCs were labeled with monoclonal antibody (mAb) at predetermined optimal concentrations. Antibodies to HLA-DR, CD16, CD19, CD56, CD40, CD36, CD86, CD80, CD83, CD34, CCR7 and matching isotype control were purchased from BD Pharmingen, Oxford, UK. Antibodies to CD3, CD14 and CD19 were obtained from ABD Serotec, Kidlington, UK. Anti-CD11c was purchased from DakoAlere, Stockport, UK. Appropriate isotype-matched control for the rest of tested antibodies was purchased from the same companies.
Flow cytometry and data analysis
Labeled samples were acquired on FACS Canto-II flow cytometer (Becton-Dickinson, UK) using FACS diva and results analyzed using offline WinList ™ software (Verity, Topsham, ME).
WinList analysis
DCs were identified as HLA-DR+ lineage-cells where lineage was a mixture of monoclonal antibodies to CD3, CD14, CD16, CD19 CD34 and CD56. DCs were further divided into myeloid (mDC, CD11c + ) and non-mDC (CD11c − ). The proportion of cells expressing surface markers was determined by comparing fluorescence to that of an isotype-matched control antibody. Enhanced normalized subtraction was used, and the results reported as percentage positive values. Figure 1a shows the identification of blood dendritic cells subtypes through the WinList analysis.
Statistics
Relationships between continuous BC variables and DCs phenotype profile values were examined using Pearson correlation coefficients (r) as appropriate. The relationship between DC phenotype profile values and BC profile and other clinicopathological parameters was assessed using with two-tailed unpaired Student's t tests. p values of less than 0.05 were considered statistically significant. All analyses were performed using the statistical software, Statistical Package for the Social Sciences, version 20.0 (SPSS, Chicago, IL).
Results
Study population
One hundred sixty consecutive patients undergoing CRC surgery at St. Mark's Hospital, London, between December 2012 and December 2013 were identified from a prospective database. After applying the selection criteria, 21 patients undergoing surgery for CRC were enrolled in the study. Thirty-one patients with recurrent or metastatic disease, 39 emergency cases, 23 receiving neoadjuvant treatment, 15 patients with diabetes, history of smoking and blood transfusion, 13 patients not willing to enroll in this study, and 18 patients with ASA status >3 were excluded.
BC parameters
The 
Discussion
This study reports correlations between DC phenotype and CT defined BC parameters. Muscle-depleted patients treated surgically for CRC appear to have DC with a lower costimulatory capacity as seen by the positive correlation between CD40 expression and LSMI. However, expression on DCs of high levels of lymph node homing marker, CCR7 and the early DC maturation marker CD83 was correlated with low levels of MA and hence myosteatosis. Fat is also associated with skeletal muscle in the form of intramyocellular lipid droplets within the cytoplasm as well as intramuscular adipocytes [14] . The excess deposition of fat within cells and tissues such as skeletal muscle is defined as ectopic fat accumulation and is considered to be a pathological condition [15] . Abnormal accumulation of fat in skeletal muscle tissue is called myosteatosis and is linked with diabetes, obesity and reduced muscle activity [16] . In contrast to fatty liver disease, the role myosteatosis in cancer immunology is poorly understood especially in patients with solid malignancies such as CRC [17] . Expression of the scavenger receptor CD36 on circulating DC was higher in patients with high MA with less steatosis, suggesting that fat could perhaps be depleted/metabolized by circulating myeloid cells in these patients. Thus, stimulatory and migratory functions as well as fatty acid metabolism in DCs might be directly sensitive to BC profiles such as myopenia and myosteatosis, providing a partial explanation of the immunodeficiency associated with CRC. If we relate the findings of this study to the fact that muscle depleted CRC patients have worse survival outcomes, then we can speculate that efficient activation by DCs in patients with good muscle tone is of paramount importance [18] . Our results are also in line as Herber et al. explanation on how the host immune system can be compromised during cancer; an increase in lipid content of DCs diminishes their capacity to present antigens from tumour cells and to activate effector T cells. Herber et al. also demonstrated that normalization of lipid levels in DCs in mice using an inhibitor of acetyl-CoA carboxylase restored the ability of DCs to stimulate T cells [2] . This link can be of particular importance if BC analysis can be used in determining immunodeficiency and hence identifying high-risk patients that will benefit from normalization of lipid levels.
Obesity alters the immune system, and its impact on the cells of the adaptive immune system has also been explored, but the DCs are probably the least explored subset [19] . Macia et al. reported that DCs from obese mice were less potent in stimulation of allogenic T cells in vitro and that this impaired functionality was linked with the secretion of immunosuppressive cytokines such as TGF-b. The obese mice also had minimal levels of functional leptin, a key adipokine linking nutrition, metabolism and immune functions [20] . In another study, diet-induced obese mice showed distorted and inefficient T cell responses to influenza infection, attributed to upregulation of immunosuppressive cytokines from lung DCs [21] .
To convey muscle depletion, obesity and declining immunity in cancer, we can assume that these conditions are linked processes, which are influenced by adipose tissue-derived and skeletal muscle-derived cytokines, known as adipokines and myokines, respectively. Evidence suggests that as adipose tissue increases the amount of the anti-inflammatory cytokine decreases whereas there is an increase in the level of the proinflammatory molecules such as leptin, TNF-a, IL-1 and IL-6 [22] . These pro-inflammatory cytokines produced especially by visceral fat negatively regulate muscle and muscle negatively regulates adipose tissue via IL-15 and other myokines [23] . Skeletal muscle tissue produces very high levels of IL-15, and levels of IL-15 are reported to increase rapidly immediately following resistance and aerobic exercise [24, 25] . IL-15 is required for DC development, survival and enhancement of their tumouricidal activity, whereas inflammatory cytokines such as TNF-a and IL-6 shorten DC cell survival [26] . In cancer, muscle mass and quality diminishes and this change may influence the production of the IL-15 and other myokines which may eventually impact negatively the ability of DCs to Bfight^the cancer insult.
The findings of the above study suggest that in CRC patients there are phenotypic differences in the peripheral blood DC compartment possibly related to host BC profile. Further studies are necessary to clarify the contribution of BC on DC impairment and to explore and optimize treatment modalities such as DC-targeted immunotherapy.
